Humana Inc. (HUM) Receives Equal Weight Rating from Barclays PLC
Humana Inc. (NYSE:HUM)‘s stock had its “equal weight” rating reaffirmed by Barclays PLC in a note issued to investors on Friday. They currently have a $191.00 price target on the insurance provider’s stock. Barclays PLC’s target price suggests a potential upside of 12.70% from the company’s current price.
HUM has been the topic of a number of other research reports. Argus reissued a “hold” rating on shares of Humana in a research note on Tuesday, August 23rd. JPMorgan Chase & Co. lowered Humana from an “overweight” rating to a “neutral” rating and cut their price target for the company from $196.00 to $150.00 in a research note on Friday, July 8th. RBC Capital Markets reaffirmed a “buy” rating and set a $224.00 price target (up previously from $220.00) on shares of Humana in a research note on Friday, July 22nd. Jefferies Group raised Humana from a “hold” rating to a “buy” rating and upped their price target for the company from $158.89 to $210.00 in a research note on Monday, July 18th. Finally, Wolfe Research initiated coverage on Humana in a research note on Tuesday, June 28th. They set a “market perform” rating and a $244.00 price target on the stock. Seven investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock has an average rating of “Buy” and an average target price of $200.50.
Humana (NYSE:HUM) opened at 169.48 on Friday. Humana has a 52 week low of $150.00 and a 52 week high of $191.65. The stock has a market cap of $25.26 billion, a PE ratio of 26.04 and a beta of 0.90. The company has a 50-day moving average price of $176.12 and a 200-day moving average price of $175.83.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 EPS for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. The company had revenue of $14 billion for the quarter, compared to analyst estimates of $13.59 billion. Humana had a return on equity of 11.11% and a net margin of 1.76%. The business’s revenue was up 2.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.67 earnings per share. Analysts anticipate that Humana will post $9.24 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Thursday, October 13th will be given a dividend of $0.29 per share. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 annualized dividend and a yield of 0.68%. Humana’s dividend payout ratio (DPR) is presently 18.18%.
Hedge funds and other institutional investors have recently modified their holdings of the stock. Virginia Retirement System bought a new position in shares of Humana during the first quarter valued at approximately $440,000. NN Investment Partners Holdings N.V. bought a new position in shares of Humana during the first quarter valued at approximately $3,104,000. Bessemer Group Inc. boosted its position in shares of Humana by 392.6% in the first quarter. Bessemer Group Inc. now owns 1,000 shares of the insurance provider’s stock valued at $183,000 after buying an additional 797 shares during the period. Spark Investment Management LLC bought a new position in shares of Humana during the first quarter valued at approximately $274,000. Finally, Aviva PLC boosted its position in shares of Humana by 1.9% in the first quarter. Aviva PLC now owns 86,580 shares of the insurance provider’s stock valued at $15,840,000 after buying an additional 1,632 shares during the period. 93.24% of the stock is owned by hedge funds and other institutional investors.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.